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Neurotrophicity, neuroprotection, neuroplasticity and neu-
rogenesis are basic biological processes of paramount im-
portance, overlapping and acting under genetic control to
generate the endogenous defense activity (EDA) which con-
tinually counteracts pathophysiological processes.
Pathological cascades contain a limited number of patho-
physiological processes. Stroke is characterized mainly by ex-
citotoxicity, oxidative stress, inflammation and apoptotic-
like processes.
Pathophysiological processes share some common mecha-
nisms with endogenous basic biological processes (e.g. exci-
totoxicity and neurotrophicity together with neuroplasticity
have, as a common important driver, the NMDAR activity;
inflammation has an important contribution for neurore-
generation, stimulating neuroplasticity, via trophic factors).
Every lesion in the nervous system triggers in the first
minute an endogenous neuroprotective reaction. An en-
dogenous repair process, combining neuroplasticity and
neurogenesis follow this as a second answer. All these pro -
cesses are initiated and regulated by neurotrophic factors.
Neurotrophic factors are produced by different players in
the brain tissue and are acting in a pleotropic way against
pathological cascades.
The same molecules, due to a complex genetically regulated
process, are able to induce, immediately after achieving the
endogenous neuroprotective effect, neuroplasticity and neu-
rogenesis as well. Therefore, they have also not only pleo -
tropic activity but also multimodal way.
Neuroprotection, neuroplasticity and neurogenesis, pro -
cesses that are apparently independent, with different con-
trol, represent in fact sequences of the same process (EDA),
regulated by neurotrophic factors.
Considering this, neurotrophic factors are important thera-
peutic agents in most important neurological disorders, in-
cluding stroke and there are many positive clinical data
proving this.
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